Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab

Arthritis and Rheumatism

Volumn 46, Issue 10, 2002, Pages 2571-2573

  Elkayam, Ori ^a   Hawkins, Philip N ^b   Lachmann, Helen ^b   Yaron, Michael ^a   Caspi, Dan ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUROTHIOMALATE; AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; GOLD SALT; HYDROXYCHLOROQUINE; INFLIXIMAB; IODINE 123; METHOTREXATE; MINOCYCLINE; PREDNISONE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; HUMAN; ISOTOPE LABELING; KIDNEY AMYLOIDOSIS; LABORATORY TEST; LEUKOPENIA; PRIORITY JOURNAL; PROTEINURIA; RHEUMATOID ARTHRITIS; SCINTIGRAPHY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0036822905     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10581     Document Type: Article

References (15)

1. Gillmore JD, Hawkins PN, Pepys MB. Amyloidosis: a review of recent diagnostic and therapeutic development. Br J Haematol 1997;99:245-56.
2. Mladenovic J, Geisic L, Kerimovic D, Aramasic M, Merovic Z. Incidence of amyloidosis in rheumatoid arthritis and ankylosing spondylitis [abstract]. Scand J Rheumatol 1975;4 Suppl 8:39.
3. Komatsuda A, Morita K, Ohtani H, Yamagushi A, Miura AB. Remission of the nephritic syndrome in a patient with renal amyloidosis due to rheumatoid arthritis treated with prednisolone and methotrexate. Am J Kidney Dis 1998;32:E7.
4. Shapiro DL, Spiera H. Regression of the nephrotic syndrome in rheumatoid arthritis and amyloidosis treated with azathioprine: a case report. Arthritis Rheum 1995;38:1851-4.
5. Kagan A, Husza M, Frumkin A, Rapoport J. Reversal of nephrotic syndrome due to AA amyloidosis in psoriatic patients on longterm colchicine treatment: case report and review of the literature. Nephron 1999;82:348-53.
6. Ahlmen M, Ahlmen J, Svalender C, Buch H. Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiency. Clin Rheumatol 1987;6:27-38.
7. Gillmore JD, Lovat L, Persey MR, Pepys M, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid protein. Lancet 2001;358:24-9.
8. Buxbaum J. The amyloidoses. In: Klippel JH, Dieppe PA, editors. Rheumatology. 2nd ed. St. Louis: Mosby; 1998. p. 5.24.7-10.
9. Laiko K, Tiitinen S, Kaarela K, Helin H, Isomaki H. Secondary amyloidosis has decreased in patients with inflammatory diseases in Finland. Clin Rheumatol 1999;18:122-3.
10. Savolainen HA. Chlorambucil in severe juvenile chronic arthritis: longterm follow-up with special reference to amyloidosis. J Rheumatol 1999;26:898-903.
11. David J, Vouyiouka O, Ansell BM, Hall A, Woo P. Amyloidosis in juvenile chronic arthritis: a morbidity and mortality study. Clin Exp Rheumatol 1993;11:85-90.
12. Moreland LW, Schiff MH, Baumgartner SW, Tindall EA, Fleischman RM, Bulpitt KJ, et al. Etanercept therapy in rheumatoid arthritis: a randomized, controlled trial. Ann Intern Med 1999;130:478-86.
13. Lipsky PE, van der Heijde DMFM, St. Clair EW, Furst DE, Breedveld FC, Kalden JR, et al, for the Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis With Concomitant Therapy Study Group. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594-602.
14. Urieli-Shoval S, Linke RP, Matzner Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease state. Current Opin Hematol 2000;7:64-9.
15. Drewe E, McDermott EM, Powell RJ. Treatment of the nephrotic syndrome with etanercept in a patient with the tumor necrosis factor receptor-associated periodic syndrome [letter]. N Engl J Med 2000;343:1044-5.